Preferred Label : peginterferon alfa-2a;

MeSH note : interferon alfa-2A chemically modified by the covalent attachment of a polyethylene glycol;

CISMeF synonym : pegasys; roche brand of peginterferon alfa-2a;

MeSH synonym : PEG-IFN alpha-2A; PEG-interferon alfa-2A; PEG-IFN alfa-2A; pegylated interferon alfa-2a; polyethylene glycol-interferon alfa-2A;

Is substance : O;

UNII : Q46947FE7K;

Details


Main resources

You can consult :


https://ansm.sante.fr/actualites/conduites-a-tenir-dans-un-contexte-mondial-de-fortes-tensions-en-pegasys-peginterferon-alfa-2a
2024
false
false
false
France
French
drug information
guidelines for drug use
peginterferon alfa-2a
peginterferon alfa-2a
peginterferon alfa-2a
onco-hematology
Ropeginterferon Alfa-2B

---
https://ansm.sante.fr/actualites/decision-du-02-12-2022-cadre-de-prescription-compassionnelle-de-pegasys-90-mg-135-mg-et-180-mg-solution-injectable-en-seringue-preremplie
https://ansm.sante.fr/tableau-acces-derogatoire/pegasys
2023
false
false
false
France
French
drug information
insurance, health, reimbursement
peginterferon alfa-2a

---
https://www.has-sante.fr/portail/jcms/c_2860526/fr/pegasys
2018
false
false
false
false
France
French
evaluation of the transparency committee
child
adolescent
peginterferon alfa-2a
peginterferon alfa-2a
hepatitis B, chronic
injections, subcutaneous
treatment outcome
antiviral agents
antiviral agents
insurance, health, reimbursement
peginterferon alfa-2a
polyethylene glycols
interferon-alpha
recombinant proteins
polyethylene glycols
interferon-alpha
recombinant proteins

---
http://www.cochrane.org/fr/CD005642/peg-interferon-alpha-2a-versus-peg-interferon-alpha-2b-pour-lhepatite-c-chronique
false
false
false
France
United Kingdom
meta-analysis
french abstract
peginterferon alfa-2a
peginterferon alfa-2b
interferon-alpha
interferon-beta
antiviral agents
hepatitis C, chronic
treatment outcome
peginterferon alfa-2a
peginterferon alfa-2b
interferon-alpha
interferon-beta
antiviral agents
hepatitis C, chronic
polyethylene glycols
recombinant proteins
polyethylene glycols
recombinant proteins

---
http://www.has-sante.fr/portail/jcms/c_1735588/fr/pegasys
2014
false
France
English
peginterferon alfa-2a
antiviral agents
insurance, health, reimbursement
hepatitis C, chronic
peginterferon alfa-2a
injections, subcutaneous
drug therapy, combination
treatment outcome
evaluation of the transparency committee
hepatitis B, chronic
adult
peginterferon alfa-2a
interferon-alpha
interferon-alpha
recombinant proteins
antiviral agents
recombinant proteins
polyethylene glycols
recombinant proteins
polyethylene glycols

---
http://www.has-sante.fr/portail/jcms/c_1735592/fr/pegasys
2014
false
France
French
child
adolescent
ribavirin
peginterferon alfa-2a
antiviral agents
insurance, health, reimbursement
hepatitis C, chronic
peginterferon alfa-2a
injections, subcutaneous
drug therapy, combination
treatment outcome
evaluation of the transparency committee
peginterferon alfa-2a
interferon-alpha
interferon-alpha
recombinant proteins
antiviral agents
recombinant proteins
polyethylene glycols
recombinant proteins
polyethylene glycols

---
http://www.has-sante.fr/portail/jcms/c_1364580/pegasys
http://www.has-sante.fr/portail/upload/docs/application/pdf/2013-03/pegasys_gamme_ri_avis2_ct12570.pdf
http://www.has-sante.fr/portail/jcms/c_713153/pegasys
http://www.has-sante.fr/portail/display.jsp?id=c_400940
http://www.has-sante.fr/portail/display.jsp?id=c_400333
http://www.has-sante.fr/portail/display.jsp?id=c_399754
http://www.has-sante.fr/portail/jcms/c_937965/pegasys
2013
France
English
French
peginterferon alfa-2a
antiviral agents
insurance, health, reimbursement
hepatitis C, chronic
peginterferon alfa-2a
injections, subcutaneous
drug therapy, combination
treatment outcome
evaluation of the transparency committee
hepatitis B, chronic
adult
peginterferon alfa-2a
interferon-alpha
interferon-alpha
recombinant proteins
antiviral agents
polyethylene glycols

---
https://www.ema.europa.eu/medicines/human/EPAR/Pegasys
2011
United Kingdom
French
English
syndication feed
Contraindications, Procedure
polyethylene glycols
polyethylene glycols
antiviral agents
hepatitis B, chronic
antiviral agents
hepatitis C, chronic
adult
antiviral agents
antiviral agents
polyethylene glycols
polyethylene glycols
polyethylene glycols
antiviral agents
drug evaluation, preclinical
drug therapy, combination
treatment outcome
drug evaluation
drug labeling
drug approval
injections, subcutaneous
antiviral agents
polyethylene glycols
antiviral agents
polyethylene glycols
drug interactions
pregnancy
breast feeding
hiv infections
peginterferon alfa-2a
peginterferon alfa-2a
polyethylene glycols
drug evaluation
package leaflet
summary of product characteristics
Contraindications, Drug

---
http://www.meddispar.fr/medicaments/3599606
http://www.meddispar.fr/medicaments/3599598
2008
France
French
polyethylene glycols
injections
drug prescriptions
legislation, drug
pharmaceutical solutions
peginterferon alfa-2a
peginterferon alfa-2a
drug information

---
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2008/14517a-fra.php
2008
Canada
French
English
hepatitis B, chronic
peripheral nervous system diseases
drug therapy, combination
polyethylene glycols
antiviral agents
peginterferon alfa-2a
polyethylene glycols
thymidine
pharmacovigilance note
Telbivudine
nucleosides
pyrimidinones

---
Nous contacter.
01/11/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.